As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...